Anti-tumor necrosis factor-alpha (TNF-α) and disease-modifying antirheumatic drugs (DMARDs) are used in the treatment of various rheumatic diseases, especially rheumatoid arthritis (RA)1. Here, TNF is linked to rheumatic disorder.